Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2.
about
Host responses in tissue repair and fibrosisMechanisms of fibrosis: therapeutic translation for fibrotic diseaseEvolving therapies for liver fibrosis.Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia.IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease.Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis.IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner.Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise.Schistosomajaponicum Eggs Induce a Proinflammatory, Anti-Fibrogenic Phenotype in Hepatic Stellate CellsHelminth Infection and Commensal Microbiota Drive Early IL-10 Production in the Skin by CD4+ T Cells That Are Functionally Suppressive.IL-10 Production in Macrophages Is Regulated by a TLR-Driven CREB-Mediated Mechanism That Is Linked to Genes Involved in Cell Metabolism.Cytokines and STATs in Liver Fibrosis.Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophyBiosensor for Hepatocellular Injury Corresponds to Experimental Scoring of Hepatosplenic Schistosomiasis in Mice.Myrrh and artesunate modulate some Th1 and Th2 cytokines secretion in Schistosoma mansoni infected miceType 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths.Monocyte subsets in schistosomiasis patients with periportal fibrosisAntagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.Immunological orchestration of liver fibrosis.Contribution of myeloid cell subsets to liver fibrosis in parasite infection.Type 2 cytokines: mechanisms and therapeutic strategies.Immunology in the liver--from homeostasis to disease.Type 2 immunity in tissue repair and fibrosis.Receptor Antagonist of IL-13 Exerts a Potential Negative Regulation During Early Infection of Human Schistosomiasis.Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production.Biomarkers of fibroproliferative healing in fibrosing idiopathic interstitial pneumonias.The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis.Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis
P2860
Q26852800-19591CBD-0528-4685-B371-AAE40045E33AQ29620307-6C82B916-D78F-47D8-ACF4-3DAD77DAE722Q30539166-26ED59D9-0886-4BFC-A85E-EB2A02FD4C57Q33735487-23B16D81-05C1-4005-9513-8EFCBBEA2D69Q34145683-EF182151-B621-4E4D-BA00-69E59A7984CAQ34166520-AB98E94A-606D-46EE-BBA2-551B3B4AE2F9Q34289189-8FCF9E99-033E-453B-B3AA-A711165198ADQ34500862-41DD2B06-8F63-4475-A749-3947931F6172Q34808848-5EFDAA91-18BB-42FD-92EC-4EB21EF957A8Q35606553-DF15197E-E872-4306-A940-94F55B2BD905Q35861973-47EF24AD-5B44-4742-AB69-B69DBFA0AF34Q35867085-A882A415-9C8C-4C63-982E-A4C8860E2B84Q36698712-533B4947-FC28-491A-A995-E7E7C0E8D813Q37027056-69024E49-B35D-4B34-98FA-F38BFB35ADCAQ37140597-FD2E5CC2-99B2-4628-8BE6-26F372B9B1BAQ37213084-173B5870-C4BD-4C75-AD77-E82FAC5ED5E9Q37686798-2B72A672-87E7-4175-B8FC-421E7D9442D7Q37706081-BA4FC7CE-645B-498C-B52C-3095E1AA51EEQ38018539-F3C66731-7755-4FDB-A76B-BC2D4789BE5FQ38046545-E139AC97-78A0-49D8-8E89-9199B7C3243DQ38424752-8844B711-032B-4B7A-B6B6-22698C6BD32AQ38693925-AA80F315-19F9-4135-8925-330CF97677B7Q40074887-CA30290D-F40C-435F-B2B2-15F45D0DA890Q40485925-D5ECBA20-13F9-4A32-8E7B-041897C800C2Q40653441-E86EE1C5-A00F-4BC9-A7C3-7D696E7E5333Q41769595-4094AA4D-A5B8-4C2B-8750-0F95E9AE718CQ44509047-23450CBA-CBAD-441F-86E0-5AD31E1654D1Q50129651-EC7BEF2A-2000-44BC-B943-CA2FEFF18FDBQ57472735-FD7E3304-82E8-496B-AFA2-A22407AB4B57
P2860
Accelerated and progressive and lethal liver fibrosis in mice that lack interleukin (IL)-10, IL-12p40, and IL-13Rα2.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@ast
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@en
type
label
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@ast
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@en
prefLabel
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@ast
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@en
P2093
P2860
P1433
P1476
Accelerated and progressive an ...... L)-10, IL-12p40, and IL-13Rα2.
@en
P2093
Allen W Cheever
Lara Megan Beers
Margaret M Mentink-Kane
Mark S Wilson
Satish K Madala
Thirumalai R Ramalingam
Thomas A Wynn
P2860
P304
P356
10.1053/J.GASTRO.2011.08.008
P407
P577
2011-08-22T00:00:00Z